CA1224717A - Antimicrobial compositions - Google Patents
Antimicrobial compositionsInfo
- Publication number
- CA1224717A CA1224717A CA000439002A CA439002A CA1224717A CA 1224717 A CA1224717 A CA 1224717A CA 000439002 A CA000439002 A CA 000439002A CA 439002 A CA439002 A CA 439002A CA 1224717 A CA1224717 A CA 1224717A
- Authority
- CA
- Canada
- Prior art keywords
- percent
- weight
- antimicrobial
- acrylonitrile
- butadiene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/10—Metal compounds
- C08K3/105—Compounds containing metals of Groups 1 to 3 or Groups 11 to 13 of the Periodic system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
Abstract
ANTIMICROBIAL COMPOSITIONS
Abstract of the Invention Antimicrobial compositions finding particular utility for coating access systems, lead devices including shunts, cannulae, catheters (18), catheter adapters, wires and other solid or hollow tubular devices used for a variety of medical purposes is provided. The composition comprises a material se-lected from the group consisting of acrylonitrile-butadiene-styrene copolymers, polyvinyl chloride, mixtures thereof, polyesters, polyurethanes, styrene-block copolymers, natural and synthetic rubbers, poly-carbonates, nylon and silicone rubber mixed with an oligodynamic material consisting essentially of phy-siological, antimicrobial metals.
Abstract of the Invention Antimicrobial compositions finding particular utility for coating access systems, lead devices including shunts, cannulae, catheters (18), catheter adapters, wires and other solid or hollow tubular devices used for a variety of medical purposes is provided. The composition comprises a material se-lected from the group consisting of acrylonitrile-butadiene-styrene copolymers, polyvinyl chloride, mixtures thereof, polyesters, polyurethanes, styrene-block copolymers, natural and synthetic rubbers, poly-carbonates, nylon and silicone rubber mixed with an oligodynamic material consisting essentially of phy-siological, antimicrobial metals.
Description
12Z~7~
ANTIMICROBIA_OMPOSITIONS
Field of the Invention This invention relates to compositions useful in making medical devices and useful in providing antimi-crobial coatings on medical devices. The invention particularly relates to antimicrobial compositions use-ful as coatings for medical connection devices and for making medical connection devices which are susceptible to touch contamination. These compositions are also useful as antimicrobial coatings for access systems and lead devices (for example, shunts, cannulae, catheters, wires, enteral feeding tubes, endotracheal tubes, per-cutaneous devices and other solid or hollow tubular devices) used for a variety of medical purposes. In addition, the compositions may be used as antimicrobial coatings for wound coverings or in the manufacture of thin, flexible, skin-like wound coverings.
Background of the Invention Indwelling urethral catheterization is performed in approximately 10 to 15 percent of hospitalized patients.
About 25 percent of these patients contract bacterial infections of the urinary tract. Two studies of note are, Garibaldi, R. A.; Burke, J. P.; Dickman, M. L.;
and Smith, C. B., "Factors Predisposing to Bacteriuria During Indwelling Urethral Cathiterization". New Engl.
J. Med., 291:215, 1974 and Kunin, C. M. and McCormack, R. C., "Prevention of Catheter-Induced Urinary-Tract Infections by Sterile Closed Drainage". New Engl. J.
Med., 274:1155, 1966.
The incidence of catheter-induced urinary tract infection still remains a problem despite various pro-phylactic measures that have been tried. Attempts to ~z2~7~7~
reduce the incidence of urinary tract infections have included the application of antibiotic ointments or other bactericidal agents to the surface of the cathe-ter, frequent bladder irrigation with concommittant prophylactic administration of antibiotics, or inhibi-tion of the growth of bacteria in urine drainage con-tainers. See, Akiyama, H. and Okamoto, S., "Prophylaxis of Indwelling Urethral Catheter Infection: Clinical Experience with a Modified Foley Catheter and Drainage System". The Journal of Urologv, 121:40, 1979. United States Patent No. 4,054,139, OligodYnamic Catheter, to Crossley, teaches a catheter, or the like, which com-prises an oligodynamic agent such as metallic silver or its compounds, alone or in association with other heavy metals such as gold, for the purpose of reducing infection associated with these devices.
It would be desirable to pro~ide compositions use-ful as coatings for urinary catheters, lead devices, medical connections susceptible to touch contamination and the like, and compositions useful as a material for making these various devices, whereby the proli-feration of bacteria thereon or in relatively close proximity thereto is inhibited. Inhibiting the proli-feration of bacteria on urinary catheters and catheter adapter connections would reduce the risk of urinary tract infections caused by bacteria accessing the urinary tract at these sites. It also would be de-sirable for the compositions to be easily applied as coatings on presently existing medical connections and devices. A desirable characteristic of such a composition would be an antimicrobial effect which is long lasting without being physiologically incompatible with nearby tissue.
1~47~7 Summary of the Invention Varlous aspects of the invention are as follows:
An antimicrobial composition comprising:
30 to 85 percent by weight of a binder consisting essentially of a material selected from the group consisting of acrylonitrile-butadiene-styrene copolymers, polyvinyl chloride, mixtures thereof, polyesters, polyurethanes, styrene-block copolymers, natural and synthetic rubbers, polycarbonates, nylon and silicone rubber; and, 15 to 70 percent by weight of an antimicrobial agent selected from the group consisting of compounds of physio-logical, antimicrobial metals and mixtures thereof.
An antimicrobial composition for coating articles comprising:
30 to 85 percent by weight of a binder consisting essentially of acrylonitrile-butadiene-styrene copolymers;
and, 15 to 70 percent by weight of an antimicrobial agent selected from the group consisting essentially of silver compounds and mixtures thereof whereby the particles of silver compound are exposed on the coating layer on the surface of the article and being sufficiently mobile to produce, within 24 hours, a solution of at least 10 6 molar concentration of silver ion concentration in a stagnant film of urine in contact with said surface.
An antimicrobial composition for coating articles comprising:
30 to 85 percent by weight of a binder consisting essentially of a mixture consisting of 35 to 65 percent by weight of acrylonitrile-butadiene-styrene copolymers and 35 to 65 percent by weight of polyvinyl chloride; and, 15 to 70 percent by weight of an antimicrobial agent consisting essentially of silver oxide whereby the particles of silver oxide are exposed on the coating layer on the outermost surface of the article and being sufficiently mobile to produce, within 24 hours, a solution of at least 10 6 molar concentration of silver ion concentration in a stagnant film of urine in contact with said surface.
`~
~ZZ'~717 ~escription of the Inventio In accordance with this inventionr antimicrobial compositions are provided which find particular utility as coatings which inhibit the proliferation of bacteria 5 near the surface of urinary catheters and th~ connec-tion between the catheter and the drainage tube, namely, the catheter/catheter adapter ~unction site. Thc anti-microbial coating on the catheter inhibits the prolifera-tion of bacteria in the area between the catheter and ~0 the walls of the urethra, and the antibacterial coatinq on the catheter adapter inhibits the pro1iferation of bacteria in the closed area connecting the catheter and the catheter adapter.
Catheters implanted in patients undergoing con-15 tinuous ambulatory peritoneal dialysis also can becoated with an antimicrohial composition of this in-vention. P.n antimicrobial composition Or this inven-tion can be applied as a coatin~ to medical shunts !
cannulae, catheters, wires and other solid or ~ollow 20 tuhular devices used for medical purposes.
Preferably, the coating using an antimicrobia~
co~position is prepared by mixing a suitable resin and a co~pound of a physiological, antimicrobial metal in an appropriate solvent for the resin. The solvent 25 should not adversely effect the activity of the metal compound as an antimicrobial agent. The coatinq can be applied to a medica~ device by di~ping in the mix-ture of resin, solvent, and physiological, antimicro-bial metal compound and thereafter allowina the solvent 30 to evaporate. Both inside and outside surfaces may be coated. Alternatively, the medical articles may be sprayed with the mixture and the solvent allowed to evaporate. Where appropriate, particularly with a latex rubber resin, a volatile liquid carrier may be - ~2247~7 used with the resin dispersed in the volatile liquid.
An article may be dipped or sprayed with this prepara-tion. upon evaporation of the volatile liquid and curing of the resin a coating for the article is pro-vided.
Indeed, articles can be made from a composition of a suitable resin and a compound of physiological, antimicrobial metal by molding the composition to form the article.
The resins used in formulating the mixture include, for example, acrylonitrile-butadiene-styrene copolymer, rigid polyvinyl chloride, curable silicones, alkoxy cured RTV silicone rubber, polyesters, rubber latexes (e.g., natural or synthetic polyisoprene), polyurethanes, styrene-block copolymers (e.g., Kraton-D*and Kraton-5*, manufactured by Shell), ethylene copolymers (e.g., vinyl acetate, ethyl acrylate, or mixtures thereof), ethylene copolymers of maleic anhydride, acrylic acid or both, polycarbonates, nylons, and polymethyl methacrylate.
Into a mixture of resin and solvent is added a quantity of physiological, antimicrobial metal compound.
Alternatively, a quantity of physiological, antimicro-bial metal compound may be mixed with a resin for direct molding of an article. Physiological, antimicrobial metals are meant to include the precious metals, such as silver, gold and platinum, and copper and zinc.
Physiological, antimicrobial metal compounds used herein include oxides and salts of preferably silver and also gold, for example: silver acetate, silver benzoate, silver carbonate, silver citrate, silver chloride, sil-ver iodide, silver oxide, silver sulfate, gold chloride and gold oxide. Platinum compounds such as chloropla-tinic acid or its salts (e.g., sodium and calcium chlo-roplatinate) may also be used. Also, compounds of * trade marks 1224~7 copper and zinc may be used, for example: oxides and salts of copper and zinc such as those indicated above for silver. Single physiological, antimicrobial metal compounds or combinations of physiological, antimicrobial metal compounds may be used.
Preferred physiological, antimicrobial metal compounds used in this invention are silver acetate, silver oxide, silver sulfate, gold chloride and a combination of silver oxide and gold chloride. Pre-ferred quantities of physiological, antimicrobialmetal compound are those sufficient to produce, within a 24 hour period, a solution of at least 10 6 molar concentration of metal ion concentration in a stagnant film of liquid in contact with a surface of an article made from a composition of this invention or an article coated with a composition of this invention.
~2Z4717 Brief Description of the Drawings For a more complete under~tanding of this inven-tion, reference should now be had to the embodiments illustrated in greater detail in the accompanying drawings.
In the drawings:
Figure 1 is an elevational view of a catheter adapter showing one end coated with an antimicrobial composition of this invention.
Figure 2 is an elevational view of a Foley catheter showing the portion of the catheter typically inserted into the urethra, coated with an antimicrobial compo-sition of this invention.
Figure 3 is a perspective view of the catheter adapter of this invention shown connecting a urinary drainage tube and a catheter.
~2Z'~717 Detailed Description of the Drawings Turning now to the drawings, Figure 1 shows a conventional catheter adapter 10 after it has been coated with an antimicrobial composition of this in-vention. Catheter adapter 10 has drainage tube end 12, catheter end 14, and injection site 16.
Catheter end 14 is spray coated or dip coated with an antimicrobial composition of this invention. The shaded portion of catheter end 14 is illustrative of the coating.
Figure 2 shows urinary catheter 18. Catheter 18 has drainage connection 20 and inflation connection 22 for inflating the catheter balloon.
The shaded portion of catheter 18 illustrates the area coated by an antimicrobial composition of this invention. Typically, this coating will be applied to that portion of catheter 18 which resides in the urethra of a patient.
A typical connection of catheter adapter 10 is illustrated in Figure 3. Catheter adapter 10 has the coated catheter end 14 connected to drainage connec-tion 20 of the catheter. Drainage tube end 12 is connected to drainage tube 24 to complete the connec-tion. Drainage tube 24 drains into a urinary drainage bag (not shown).
The risk of touch contamination of catheter end 14 is reduced by coating catheter end 14 of catheter adapter 10 with an antimicrobial composition of the present invention. Reducing the risk of touch contami-nation of catheter end 14 reduces the risk of subsequent urinary tract infection caused by a contaminated catheter adapter.
The antimicrobial composition coating catheter 18 inhibits the proliferation and migration of bacteria ~224717 in a stagnant film between the coated catheter walls and the walls of the urethra. By inhibiting the pro-liferation and migration of bacteria through this route, subsequent urinary tract infection caused by such proliferation and migration of bacteria is re-duced.
The examples below are offered for illustrative purposes only and are not intended to limit the scope of the invention of this application, which is as de-fined in the claims below.
A mixture was made of 50 milliliters of methylenechloride, 5 grams of acrylonitrile-butadiene-styrene copolymer (LUSTRAN 240-29, a trademark of the Monsanto Company), and 1.2 grams of silver oxide powder. The mixture was stirred for approximately one hour. A
polyvinyl chloride catheter adapter, used to connect a urinary catheter and drainage tubing for a urinary drainage connector, was coated on the exterior and the interior by dipping the connector into the mixture.
Upon evaporation of the solvent, an antimicrobial coat-ing remained bonded to the catheter adapter. Catheter adapters can also be sprayed with the mixture.
A mixture was made by combining 50 milliliters of tetrahydrofuran, 5 grams of polyvinyl chloride (Alpha Plastics and Chemicals, clear rigid vinyl 2212/7-118), and 1.2 grams of silver oxide powder. The mixture was stirred for about one hour.
Vinyl compatible catheter adapters may be either dip coated or spray coated with this mixture. By dip coating the catheter adapter, the exterior and interior ~ZZ~717 surfaces may be conveniently coated. Upon ev~poration of the solvent, tetrahydrofuran, an antimicrobial coat-ing will remain bonded to the device.
Equivalent results may be obtained when a mixture is made by combining 25 milliliters of tetrahydrofuran, 25 milliliters of methylene chloride, 2.5 grams of acrylonitrile-butadiene-styrene copolymer (LUSTR~I
240-29), 2.5 grams of polyvinyl chloride (Alpha Plastics and Chemicals, clear rigid vinyl 2212/7-118), and 1.2 grams of silver oxide powder. The mixture may be stirred for about one hour.
A catheter adapter may be either dip coated or spray coated with this mixture. Upon evaporation of the solvents, an antimicrobial coating will remain bonded to the device.
A mixture was made by combining 10 milliliters of alkoxy curing RTV rubber, 65 milliliters of FREON TF
solvent (FREON is a trademark of E. I. du pont de Nemours & Co.), and 5 grams of silver oxide powder. The mixture was stirred for about one hour.
A silicone rubber Foley catheter was dipped into this mixture and upon evaporation of the solvent and curing of the RTV, a flexible, antimicrobial coating on the interior and exterior surfaces of the silicone rubber catheter was provided. The coating adhered well to the catheter. Spray coating of the catheter is a viable alternative.
A mixture was made by combining 100 milliliters lZZ47~
of tetrahydrofuran, 5 grams of acrylonitrile-butadiene-styrene copolymer (LUSTRAN 240-29), and 1 gram of silver acetate. The mixture was stirred for about one hour.
Acrylonitrile-butadiene-styrene compatible devices may be spray or dip coated with the mixture. Upon evapora-tion of the solvent, an antimicrobial coating will remain on the device.
Equivalent results may be obtained when a mixture is made by combining 100 milliliters of methylene chlo-ride, 5 gra~s of acrylonitrile-butadiene-styrene copoly-mer (LUSTRAN 240-29), and 1 gram of silver sulfate. The mixture may be stirred for about one hour. Acrylonitrile-butadiene-styrene compatible devices may be spray or dip coated with the mixture. Upon evaporation of the solvent, an antimicrobial coating will remain on the device.
EXA~PLE 7 Equivalent results may be obtained when a mixture is made by combining 50 milliliters of tetrahydrofuran, 5 grams of polyvinyl chloride (Alpha Plastics and Chemicals, clear rigid vinyl 2212/7-118), and 1.2 grams of gold chloride powder. The mixture may be stirred for about one hour. Polyvinyl chloride compatible de-vices may be spray or dip coated with the mixture. Upon evaporation of the solvent, an antimicrobial coating will remain on the device.
Equivalent results may be obtained when a mixture is made by combining 25 milliliters of tetrahydrofuran, 25 milliliters of methylene chloride, 2.5 grams of acrylonitrile-butadiene-styrene copolymer tLUSTRAN
~22~17 240-29), 2.5 grams of polyvinyl chloride (Alpha Plastics and Chemicals, clear rigid vinyl 2212/7-118), and 1.2 grams of gold chloride powder. The mixture may be stirred for about one hour. Devices may be either dip coated or spray coated with this mixture. Upon evaporation of the solvents, an antimicrobial coating remains bonded to the device.
Equivalent results may be obtained when a mixture is made by combining 10 milliliters of alkoxy curing RTV, 65 milliliters of FREON TF solvent and 5 grams of gold chloride powder. The mixture may be stirred for about one hour.
A silicone rubber Foley catheter or other silicone lS rubber medical device mav be dipped into this mixture and upon evaporation of the solvent and curing of the RTV, a flexible, antimicrobial coating for the silicone rubber catheter will be provided. Spray coating of the catheter is also a viable alternative.
Equivalent results may be obtained when a mixture is made by combining 50 milliliters of tetrahydrofuran, 5 grams of polyvinyl chloride (Alpha Plastics and Chemicals, clear rigid vinyl 2212/7-118), 1.2 grams of silver oxide powder, and 0.1 gram of gold chloride powder. The mixture may be stirred for about one hour.
Vinyl compatible catheter adapters or other medi-cal devices may be either dip coated or spray coated with this mixture. Upon evaporation of the solvent, tetrahydrofuran, an antimicrobial coating will remain on the device.
~224717 Equivalent results may be obtained when a mixture is made by combining 25 milliliters of tetrahydrofuran, 25 milliliters of methylene chloride, 2.5 grams of acrylonitrile-butadiene-stryrene copolymer (LUSTRAN
240-29), 2.5 grams of polyvinyl chloride (Alpha Plastics and Chemicals, clear rigid vinyl 2212/7-ll~), 1.2 grams of silver oxide powder, and 0.1 gram of gold chloride powder. The mixture may be stirred for about one hour.
Devices may be either dip coated or spray coated with this mixture. Upon evaporation of the solvents, an antimicrobial coating will remain on the device.
Equivalent results may be obtained when a mixture is made by combining 10 milliliters of alkoxy curing RTV, 65 milliliters of FREON TF solvent, 5 grams of silver oxide powder, and 0.5 gram of gold chloride powder. The mixture may be stirred for about one hour.
A silicone rubber Foley catheter or other silicone rubber medical device may be dipped into this mixture and upon evaporation of the solvent and curing of the RTV, a flexible, antimicrobial coating for the silicone rubber catheter is provided. Spray coating of the catheter is also an alternative application means.
Equivalent results may be obtained when a mixture is made by combining 100 milliliters of natural rubber latex with 10 grams of silver oxide powder. The mixture may be stirred until the silver oxide is dispersed.
Cured latex rubber devices may be dip coated with this ~2Z~7~7 mixture. Upon evaporation of the volatile liquid car-rier and curing of the coating mixture, an antimicrobial coating having high elastomeric characteristics will remain adhered to the device.
Equivalent results may be obtained when a mixture is made by combining 50 milliliters of methylene chlo-ride, 5 grams of acrylonitrile-butadiene-styrene copoly-mer (LUSTRAN 240-29), and 1.2 grams of copper oxide powder. The mixture may be stirred for about one hour.
A catheter adapter may be either dip coated or spray coated with this mixture. Upon evaporation of the solvent, an antimicrobial coating will remain bonded to the device.
Equivalent results may be obtained when a mixture is made by combining 50 milliliters of methylene chlo-ride, 5 grams of acrylonitrile-butadiene-styrene copoly-mer (LUSTRAN 240-29), and 1.2 grams of zinc oxide powder.
The mixture may be stirred for about one hour. A cathe-ter adapter may be either dip coated or spray coated with this mixture. Upon evaporation of the solvent, an antimicrobial coating will remain bonded to the de-vlce .
WHAT IS CLAIMED IS:
ANTIMICROBIA_OMPOSITIONS
Field of the Invention This invention relates to compositions useful in making medical devices and useful in providing antimi-crobial coatings on medical devices. The invention particularly relates to antimicrobial compositions use-ful as coatings for medical connection devices and for making medical connection devices which are susceptible to touch contamination. These compositions are also useful as antimicrobial coatings for access systems and lead devices (for example, shunts, cannulae, catheters, wires, enteral feeding tubes, endotracheal tubes, per-cutaneous devices and other solid or hollow tubular devices) used for a variety of medical purposes. In addition, the compositions may be used as antimicrobial coatings for wound coverings or in the manufacture of thin, flexible, skin-like wound coverings.
Background of the Invention Indwelling urethral catheterization is performed in approximately 10 to 15 percent of hospitalized patients.
About 25 percent of these patients contract bacterial infections of the urinary tract. Two studies of note are, Garibaldi, R. A.; Burke, J. P.; Dickman, M. L.;
and Smith, C. B., "Factors Predisposing to Bacteriuria During Indwelling Urethral Cathiterization". New Engl.
J. Med., 291:215, 1974 and Kunin, C. M. and McCormack, R. C., "Prevention of Catheter-Induced Urinary-Tract Infections by Sterile Closed Drainage". New Engl. J.
Med., 274:1155, 1966.
The incidence of catheter-induced urinary tract infection still remains a problem despite various pro-phylactic measures that have been tried. Attempts to ~z2~7~7~
reduce the incidence of urinary tract infections have included the application of antibiotic ointments or other bactericidal agents to the surface of the cathe-ter, frequent bladder irrigation with concommittant prophylactic administration of antibiotics, or inhibi-tion of the growth of bacteria in urine drainage con-tainers. See, Akiyama, H. and Okamoto, S., "Prophylaxis of Indwelling Urethral Catheter Infection: Clinical Experience with a Modified Foley Catheter and Drainage System". The Journal of Urologv, 121:40, 1979. United States Patent No. 4,054,139, OligodYnamic Catheter, to Crossley, teaches a catheter, or the like, which com-prises an oligodynamic agent such as metallic silver or its compounds, alone or in association with other heavy metals such as gold, for the purpose of reducing infection associated with these devices.
It would be desirable to pro~ide compositions use-ful as coatings for urinary catheters, lead devices, medical connections susceptible to touch contamination and the like, and compositions useful as a material for making these various devices, whereby the proli-feration of bacteria thereon or in relatively close proximity thereto is inhibited. Inhibiting the proli-feration of bacteria on urinary catheters and catheter adapter connections would reduce the risk of urinary tract infections caused by bacteria accessing the urinary tract at these sites. It also would be de-sirable for the compositions to be easily applied as coatings on presently existing medical connections and devices. A desirable characteristic of such a composition would be an antimicrobial effect which is long lasting without being physiologically incompatible with nearby tissue.
1~47~7 Summary of the Invention Varlous aspects of the invention are as follows:
An antimicrobial composition comprising:
30 to 85 percent by weight of a binder consisting essentially of a material selected from the group consisting of acrylonitrile-butadiene-styrene copolymers, polyvinyl chloride, mixtures thereof, polyesters, polyurethanes, styrene-block copolymers, natural and synthetic rubbers, polycarbonates, nylon and silicone rubber; and, 15 to 70 percent by weight of an antimicrobial agent selected from the group consisting of compounds of physio-logical, antimicrobial metals and mixtures thereof.
An antimicrobial composition for coating articles comprising:
30 to 85 percent by weight of a binder consisting essentially of acrylonitrile-butadiene-styrene copolymers;
and, 15 to 70 percent by weight of an antimicrobial agent selected from the group consisting essentially of silver compounds and mixtures thereof whereby the particles of silver compound are exposed on the coating layer on the surface of the article and being sufficiently mobile to produce, within 24 hours, a solution of at least 10 6 molar concentration of silver ion concentration in a stagnant film of urine in contact with said surface.
An antimicrobial composition for coating articles comprising:
30 to 85 percent by weight of a binder consisting essentially of a mixture consisting of 35 to 65 percent by weight of acrylonitrile-butadiene-styrene copolymers and 35 to 65 percent by weight of polyvinyl chloride; and, 15 to 70 percent by weight of an antimicrobial agent consisting essentially of silver oxide whereby the particles of silver oxide are exposed on the coating layer on the outermost surface of the article and being sufficiently mobile to produce, within 24 hours, a solution of at least 10 6 molar concentration of silver ion concentration in a stagnant film of urine in contact with said surface.
`~
~ZZ'~717 ~escription of the Inventio In accordance with this inventionr antimicrobial compositions are provided which find particular utility as coatings which inhibit the proliferation of bacteria 5 near the surface of urinary catheters and th~ connec-tion between the catheter and the drainage tube, namely, the catheter/catheter adapter ~unction site. Thc anti-microbial coating on the catheter inhibits the prolifera-tion of bacteria in the area between the catheter and ~0 the walls of the urethra, and the antibacterial coatinq on the catheter adapter inhibits the pro1iferation of bacteria in the closed area connecting the catheter and the catheter adapter.
Catheters implanted in patients undergoing con-15 tinuous ambulatory peritoneal dialysis also can becoated with an antimicrohial composition of this in-vention. P.n antimicrobial composition Or this inven-tion can be applied as a coatin~ to medical shunts !
cannulae, catheters, wires and other solid or ~ollow 20 tuhular devices used for medical purposes.
Preferably, the coating using an antimicrobia~
co~position is prepared by mixing a suitable resin and a co~pound of a physiological, antimicrobial metal in an appropriate solvent for the resin. The solvent 25 should not adversely effect the activity of the metal compound as an antimicrobial agent. The coatinq can be applied to a medica~ device by di~ping in the mix-ture of resin, solvent, and physiological, antimicro-bial metal compound and thereafter allowina the solvent 30 to evaporate. Both inside and outside surfaces may be coated. Alternatively, the medical articles may be sprayed with the mixture and the solvent allowed to evaporate. Where appropriate, particularly with a latex rubber resin, a volatile liquid carrier may be - ~2247~7 used with the resin dispersed in the volatile liquid.
An article may be dipped or sprayed with this prepara-tion. upon evaporation of the volatile liquid and curing of the resin a coating for the article is pro-vided.
Indeed, articles can be made from a composition of a suitable resin and a compound of physiological, antimicrobial metal by molding the composition to form the article.
The resins used in formulating the mixture include, for example, acrylonitrile-butadiene-styrene copolymer, rigid polyvinyl chloride, curable silicones, alkoxy cured RTV silicone rubber, polyesters, rubber latexes (e.g., natural or synthetic polyisoprene), polyurethanes, styrene-block copolymers (e.g., Kraton-D*and Kraton-5*, manufactured by Shell), ethylene copolymers (e.g., vinyl acetate, ethyl acrylate, or mixtures thereof), ethylene copolymers of maleic anhydride, acrylic acid or both, polycarbonates, nylons, and polymethyl methacrylate.
Into a mixture of resin and solvent is added a quantity of physiological, antimicrobial metal compound.
Alternatively, a quantity of physiological, antimicro-bial metal compound may be mixed with a resin for direct molding of an article. Physiological, antimicrobial metals are meant to include the precious metals, such as silver, gold and platinum, and copper and zinc.
Physiological, antimicrobial metal compounds used herein include oxides and salts of preferably silver and also gold, for example: silver acetate, silver benzoate, silver carbonate, silver citrate, silver chloride, sil-ver iodide, silver oxide, silver sulfate, gold chloride and gold oxide. Platinum compounds such as chloropla-tinic acid or its salts (e.g., sodium and calcium chlo-roplatinate) may also be used. Also, compounds of * trade marks 1224~7 copper and zinc may be used, for example: oxides and salts of copper and zinc such as those indicated above for silver. Single physiological, antimicrobial metal compounds or combinations of physiological, antimicrobial metal compounds may be used.
Preferred physiological, antimicrobial metal compounds used in this invention are silver acetate, silver oxide, silver sulfate, gold chloride and a combination of silver oxide and gold chloride. Pre-ferred quantities of physiological, antimicrobialmetal compound are those sufficient to produce, within a 24 hour period, a solution of at least 10 6 molar concentration of metal ion concentration in a stagnant film of liquid in contact with a surface of an article made from a composition of this invention or an article coated with a composition of this invention.
~2Z4717 Brief Description of the Drawings For a more complete under~tanding of this inven-tion, reference should now be had to the embodiments illustrated in greater detail in the accompanying drawings.
In the drawings:
Figure 1 is an elevational view of a catheter adapter showing one end coated with an antimicrobial composition of this invention.
Figure 2 is an elevational view of a Foley catheter showing the portion of the catheter typically inserted into the urethra, coated with an antimicrobial compo-sition of this invention.
Figure 3 is a perspective view of the catheter adapter of this invention shown connecting a urinary drainage tube and a catheter.
~2Z'~717 Detailed Description of the Drawings Turning now to the drawings, Figure 1 shows a conventional catheter adapter 10 after it has been coated with an antimicrobial composition of this in-vention. Catheter adapter 10 has drainage tube end 12, catheter end 14, and injection site 16.
Catheter end 14 is spray coated or dip coated with an antimicrobial composition of this invention. The shaded portion of catheter end 14 is illustrative of the coating.
Figure 2 shows urinary catheter 18. Catheter 18 has drainage connection 20 and inflation connection 22 for inflating the catheter balloon.
The shaded portion of catheter 18 illustrates the area coated by an antimicrobial composition of this invention. Typically, this coating will be applied to that portion of catheter 18 which resides in the urethra of a patient.
A typical connection of catheter adapter 10 is illustrated in Figure 3. Catheter adapter 10 has the coated catheter end 14 connected to drainage connec-tion 20 of the catheter. Drainage tube end 12 is connected to drainage tube 24 to complete the connec-tion. Drainage tube 24 drains into a urinary drainage bag (not shown).
The risk of touch contamination of catheter end 14 is reduced by coating catheter end 14 of catheter adapter 10 with an antimicrobial composition of the present invention. Reducing the risk of touch contami-nation of catheter end 14 reduces the risk of subsequent urinary tract infection caused by a contaminated catheter adapter.
The antimicrobial composition coating catheter 18 inhibits the proliferation and migration of bacteria ~224717 in a stagnant film between the coated catheter walls and the walls of the urethra. By inhibiting the pro-liferation and migration of bacteria through this route, subsequent urinary tract infection caused by such proliferation and migration of bacteria is re-duced.
The examples below are offered for illustrative purposes only and are not intended to limit the scope of the invention of this application, which is as de-fined in the claims below.
A mixture was made of 50 milliliters of methylenechloride, 5 grams of acrylonitrile-butadiene-styrene copolymer (LUSTRAN 240-29, a trademark of the Monsanto Company), and 1.2 grams of silver oxide powder. The mixture was stirred for approximately one hour. A
polyvinyl chloride catheter adapter, used to connect a urinary catheter and drainage tubing for a urinary drainage connector, was coated on the exterior and the interior by dipping the connector into the mixture.
Upon evaporation of the solvent, an antimicrobial coat-ing remained bonded to the catheter adapter. Catheter adapters can also be sprayed with the mixture.
A mixture was made by combining 50 milliliters of tetrahydrofuran, 5 grams of polyvinyl chloride (Alpha Plastics and Chemicals, clear rigid vinyl 2212/7-118), and 1.2 grams of silver oxide powder. The mixture was stirred for about one hour.
Vinyl compatible catheter adapters may be either dip coated or spray coated with this mixture. By dip coating the catheter adapter, the exterior and interior ~ZZ~717 surfaces may be conveniently coated. Upon ev~poration of the solvent, tetrahydrofuran, an antimicrobial coat-ing will remain bonded to the device.
Equivalent results may be obtained when a mixture is made by combining 25 milliliters of tetrahydrofuran, 25 milliliters of methylene chloride, 2.5 grams of acrylonitrile-butadiene-styrene copolymer (LUSTR~I
240-29), 2.5 grams of polyvinyl chloride (Alpha Plastics and Chemicals, clear rigid vinyl 2212/7-118), and 1.2 grams of silver oxide powder. The mixture may be stirred for about one hour.
A catheter adapter may be either dip coated or spray coated with this mixture. Upon evaporation of the solvents, an antimicrobial coating will remain bonded to the device.
A mixture was made by combining 10 milliliters of alkoxy curing RTV rubber, 65 milliliters of FREON TF
solvent (FREON is a trademark of E. I. du pont de Nemours & Co.), and 5 grams of silver oxide powder. The mixture was stirred for about one hour.
A silicone rubber Foley catheter was dipped into this mixture and upon evaporation of the solvent and curing of the RTV, a flexible, antimicrobial coating on the interior and exterior surfaces of the silicone rubber catheter was provided. The coating adhered well to the catheter. Spray coating of the catheter is a viable alternative.
A mixture was made by combining 100 milliliters lZZ47~
of tetrahydrofuran, 5 grams of acrylonitrile-butadiene-styrene copolymer (LUSTRAN 240-29), and 1 gram of silver acetate. The mixture was stirred for about one hour.
Acrylonitrile-butadiene-styrene compatible devices may be spray or dip coated with the mixture. Upon evapora-tion of the solvent, an antimicrobial coating will remain on the device.
Equivalent results may be obtained when a mixture is made by combining 100 milliliters of methylene chlo-ride, 5 gra~s of acrylonitrile-butadiene-styrene copoly-mer (LUSTRAN 240-29), and 1 gram of silver sulfate. The mixture may be stirred for about one hour. Acrylonitrile-butadiene-styrene compatible devices may be spray or dip coated with the mixture. Upon evaporation of the solvent, an antimicrobial coating will remain on the device.
EXA~PLE 7 Equivalent results may be obtained when a mixture is made by combining 50 milliliters of tetrahydrofuran, 5 grams of polyvinyl chloride (Alpha Plastics and Chemicals, clear rigid vinyl 2212/7-118), and 1.2 grams of gold chloride powder. The mixture may be stirred for about one hour. Polyvinyl chloride compatible de-vices may be spray or dip coated with the mixture. Upon evaporation of the solvent, an antimicrobial coating will remain on the device.
Equivalent results may be obtained when a mixture is made by combining 25 milliliters of tetrahydrofuran, 25 milliliters of methylene chloride, 2.5 grams of acrylonitrile-butadiene-styrene copolymer tLUSTRAN
~22~17 240-29), 2.5 grams of polyvinyl chloride (Alpha Plastics and Chemicals, clear rigid vinyl 2212/7-118), and 1.2 grams of gold chloride powder. The mixture may be stirred for about one hour. Devices may be either dip coated or spray coated with this mixture. Upon evaporation of the solvents, an antimicrobial coating remains bonded to the device.
Equivalent results may be obtained when a mixture is made by combining 10 milliliters of alkoxy curing RTV, 65 milliliters of FREON TF solvent and 5 grams of gold chloride powder. The mixture may be stirred for about one hour.
A silicone rubber Foley catheter or other silicone lS rubber medical device mav be dipped into this mixture and upon evaporation of the solvent and curing of the RTV, a flexible, antimicrobial coating for the silicone rubber catheter will be provided. Spray coating of the catheter is also a viable alternative.
Equivalent results may be obtained when a mixture is made by combining 50 milliliters of tetrahydrofuran, 5 grams of polyvinyl chloride (Alpha Plastics and Chemicals, clear rigid vinyl 2212/7-118), 1.2 grams of silver oxide powder, and 0.1 gram of gold chloride powder. The mixture may be stirred for about one hour.
Vinyl compatible catheter adapters or other medi-cal devices may be either dip coated or spray coated with this mixture. Upon evaporation of the solvent, tetrahydrofuran, an antimicrobial coating will remain on the device.
~224717 Equivalent results may be obtained when a mixture is made by combining 25 milliliters of tetrahydrofuran, 25 milliliters of methylene chloride, 2.5 grams of acrylonitrile-butadiene-stryrene copolymer (LUSTRAN
240-29), 2.5 grams of polyvinyl chloride (Alpha Plastics and Chemicals, clear rigid vinyl 2212/7-ll~), 1.2 grams of silver oxide powder, and 0.1 gram of gold chloride powder. The mixture may be stirred for about one hour.
Devices may be either dip coated or spray coated with this mixture. Upon evaporation of the solvents, an antimicrobial coating will remain on the device.
Equivalent results may be obtained when a mixture is made by combining 10 milliliters of alkoxy curing RTV, 65 milliliters of FREON TF solvent, 5 grams of silver oxide powder, and 0.5 gram of gold chloride powder. The mixture may be stirred for about one hour.
A silicone rubber Foley catheter or other silicone rubber medical device may be dipped into this mixture and upon evaporation of the solvent and curing of the RTV, a flexible, antimicrobial coating for the silicone rubber catheter is provided. Spray coating of the catheter is also an alternative application means.
Equivalent results may be obtained when a mixture is made by combining 100 milliliters of natural rubber latex with 10 grams of silver oxide powder. The mixture may be stirred until the silver oxide is dispersed.
Cured latex rubber devices may be dip coated with this ~2Z~7~7 mixture. Upon evaporation of the volatile liquid car-rier and curing of the coating mixture, an antimicrobial coating having high elastomeric characteristics will remain adhered to the device.
Equivalent results may be obtained when a mixture is made by combining 50 milliliters of methylene chlo-ride, 5 grams of acrylonitrile-butadiene-styrene copoly-mer (LUSTRAN 240-29), and 1.2 grams of copper oxide powder. The mixture may be stirred for about one hour.
A catheter adapter may be either dip coated or spray coated with this mixture. Upon evaporation of the solvent, an antimicrobial coating will remain bonded to the device.
Equivalent results may be obtained when a mixture is made by combining 50 milliliters of methylene chlo-ride, 5 grams of acrylonitrile-butadiene-styrene copoly-mer (LUSTRAN 240-29), and 1.2 grams of zinc oxide powder.
The mixture may be stirred for about one hour. A cathe-ter adapter may be either dip coated or spray coated with this mixture. Upon evaporation of the solvent, an antimicrobial coating will remain bonded to the de-vlce .
WHAT IS CLAIMED IS:
Claims (8)
1. An antimicrobial composition comprising:
30 to 85 percent by weight of a binder consisting essentially of a material selected from the group con-sisting of acrylonitrile-butadiene-styrene copolymers, polyvinyl chloride, mixtures thereof, polyesters, poly-urethanes, styrene-block copolymers, natural and syn-thetic rubbers, polycarbonates, nylon and silicone rubber; and, 15 to 70 percent by weight of an antimicrobial agent selected from the group consisting of compounds of physiological, antimicrobial metals and mixtures thereof.
30 to 85 percent by weight of a binder consisting essentially of a material selected from the group con-sisting of acrylonitrile-butadiene-styrene copolymers, polyvinyl chloride, mixtures thereof, polyesters, poly-urethanes, styrene-block copolymers, natural and syn-thetic rubbers, polycarbonates, nylon and silicone rubber; and, 15 to 70 percent by weight of an antimicrobial agent selected from the group consisting of compounds of physiological, antimicrobial metals and mixtures thereof.
2. The antimicrobial composition of Claim 1 in which said mixtures of acrylonitrile-butadiene-styrene copolymers and polyvinyl chloride consist of 25 to 75 percent by weight of acrylonitrile-butadiene-styrene copolymers and 25 to 75 percent by weight of polyvinyl chloride.
3. The antimicrobial composition of Claim 1 in which said antimicrobial agent is selected from the group consisting of oxides and salts of silver and gold.
4. The antimicrobial composition of Claim 1 in which said antimicrobial agent is selected from the group consisting of silver compounds.
5. The antimicrobial composition of Claim 4 in which said antimicrobial agent is silver oxide.
6. An antimicrobial composition for coating articles comprising:
30 to 85 percent by weight of a binder consisting essentially of acrylonitrile-butadiene-styrene copoly-mers; and, 15 to 70 percent by weight of an antimicrobial agent selected from the group consisting essentially of silver compounds and mixtures thereof whereby the particles of silver compound are exposed on the coating layer on the surface of the article and being sufficiently mobile to produce, within 24 hours, a solution of at least 10-6 molar concentration of silver ion concentration in a stagnant film of urine in contact with said surface.
30 to 85 percent by weight of a binder consisting essentially of acrylonitrile-butadiene-styrene copoly-mers; and, 15 to 70 percent by weight of an antimicrobial agent selected from the group consisting essentially of silver compounds and mixtures thereof whereby the particles of silver compound are exposed on the coating layer on the surface of the article and being sufficiently mobile to produce, within 24 hours, a solution of at least 10-6 molar concentration of silver ion concentration in a stagnant film of urine in contact with said surface.
7. An antimicrobial composition for coating articles comprising:
30 to 85 percent by weight of a binder consisting essentially of a mixture consisting of 35 to 65 percent by weight of acrylonitrile-butadiene-styrene copolymers and 35 to 65 percent by weight of polyvinyl chloride;
and, 15 to 70 percent by weight of an antimicrobial agent consisting essentially of silver oxide whereby the particles of silver oxide are exposed on the coating layer on the outermost surface of the article and being sufficiently mobile to produce, within 24 hours, a solution of at least 10-6 molar concentration of silver ion concentration in a stagnant film of urine in contact with said surface.
30 to 85 percent by weight of a binder consisting essentially of a mixture consisting of 35 to 65 percent by weight of acrylonitrile-butadiene-styrene copolymers and 35 to 65 percent by weight of polyvinyl chloride;
and, 15 to 70 percent by weight of an antimicrobial agent consisting essentially of silver oxide whereby the particles of silver oxide are exposed on the coating layer on the outermost surface of the article and being sufficiently mobile to produce, within 24 hours, a solution of at least 10-6 molar concentration of silver ion concentration in a stagnant film of urine in contact with said surface.
8. The antimicrobial composition of Claim 7 in which said mixtures of acrylonitrile-butadiene-styrene copolymers and polyvinyl chloride consist of 50 percent by weight of acrylonitrile-butadiene-styrene copolymers and 50 percent by weight of polyvinyl chloride.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43950682A | 1982-11-05 | 1982-11-05 | |
| US439,506 | 1982-11-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1224717A true CA1224717A (en) | 1987-07-28 |
Family
ID=23744984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000439002A Expired CA1224717A (en) | 1982-11-05 | 1983-10-14 | Antimicrobial compositions |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0124536A4 (en) |
| CA (1) | CA1224717A (en) |
| ES (1) | ES527051A0 (en) |
| WO (1) | WO1984001721A1 (en) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4603152A (en) * | 1982-11-05 | 1986-07-29 | Baxter Travenol Laboratories, Inc. | Antimicrobial compositions |
| JPS60501041A (en) * | 1983-04-18 | 1985-07-11 | バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテッド | Articles and compositions that provide antimicrobial effects during urination |
| DE3587286T2 (en) * | 1984-12-28 | 1993-09-23 | Johnson Matthey Plc | ANTIMICROBIAL COMPOSITIONS. |
| US4810247A (en) * | 1985-11-21 | 1989-03-07 | Glassman Jacob A | Urinary catheter and penile-cup |
| DE3729253A1 (en) * | 1987-09-02 | 1989-03-23 | Ulrich Dr Mueller | Device for preventing infections in external fixators in bone surgery |
| DE4222040C1 (en) * | 1992-07-04 | 1994-03-10 | Sterimed Gmbh | Catheter set |
| US5848995A (en) * | 1993-04-09 | 1998-12-15 | Walder; Anthony J. | Anti-infective medical article and method for its preparation |
| DE4403016A1 (en) * | 1994-02-01 | 1995-08-03 | Krall Theodor Dipl Ing | Microbicidal plastic articles partic. for medical use |
| DE19607314A1 (en) * | 1996-02-27 | 1997-08-28 | Orthomed Chirurgische Instr Gm | Body exhibiting antibacterial activity for use as a medical or surgical aid |
| US6191192B1 (en) | 1997-06-23 | 2001-02-20 | Toyo Boseki Kabushiki Kaisha | Antibacterial polymeric moldings |
| US6605751B1 (en) | 1997-11-14 | 2003-08-12 | Acrymed | Silver-containing compositions, devices and methods for making |
| IT1300023B1 (en) * | 1998-05-11 | 2000-04-04 | Medistar Srl | BODY FLUID COLLECTION DEVICE. |
| AU5928299A (en) * | 1998-09-17 | 2000-04-03 | Kdf Fluid Treatment, Inc. | Antimicrobial urinary catheter |
| US6716895B1 (en) | 1999-12-15 | 2004-04-06 | C.R. Bard, Inc. | Polymer compositions containing colloids of silver salts |
| US7179849B2 (en) * | 1999-12-15 | 2007-02-20 | C. R. Bard, Inc. | Antimicrobial compositions containing colloids of oligodynamic metals |
| US8679523B2 (en) | 1999-12-30 | 2014-03-25 | Kimberly-Clark Worldwide, Inc. | Oxygen-delivery closed cell foam matrix for wound treatment |
| US6475196B1 (en) * | 2000-08-18 | 2002-11-05 | Minimed Inc. | Subcutaneous infusion cannula |
| DE10043151A1 (en) | 2000-08-31 | 2002-03-28 | Peter Steinruecke | Bone cement with antimicrobial effectiveness |
| DE60142180D1 (en) * | 2000-11-29 | 2010-07-01 | Convatec Technologies Inc | LIGHT-STABILIZED ANTIMICROBIAL AGENTS |
| DE10146050B4 (en) | 2001-09-18 | 2007-11-29 | Bio-Gate Ag | Process for the preparation of an antimicrobial adhesive and coating material |
| US7105175B2 (en) * | 2002-06-19 | 2006-09-12 | Boston Scientific Scimed, Inc. | Implantable or insertable medical devices for controlled delivery of a therapeutic agent |
| US20030236513A1 (en) * | 2002-06-19 | 2003-12-25 | Scimed Life Systems, Inc. | Implantable or insertable medical devices for controlled delivery of a therapeutic agent |
| US7745509B2 (en) | 2003-12-05 | 2010-06-29 | 3M Innovative Properties Company | Polymer compositions with bioactive agent, medical articles, and methods |
| AU2004296174A1 (en) * | 2003-12-15 | 2005-06-23 | Nitricare Hb | Device and method for administering therapeutic agents |
| BRPI0513967A (en) | 2004-07-30 | 2008-05-20 | Acrymed Inc | antimicrobial silver compositions |
| CN102783499A (en) | 2004-07-30 | 2012-11-21 | 金伯利-克拉克环球有限公司 | Antimicrobial devices and compositions |
| US8399027B2 (en) * | 2005-04-14 | 2013-03-19 | 3M Innovative Properties Company | Silver coatings and methods of manufacture |
| US20060233888A1 (en) * | 2005-04-14 | 2006-10-19 | 3M Innovative Properties Company | Silver coatings and methods of manufacture |
| GB0525504D0 (en) | 2005-12-14 | 2006-01-25 | Bristol Myers Squibb Co | Antimicrobial composition |
| US20070166399A1 (en) | 2006-01-13 | 2007-07-19 | 3M Innovative Properties Company | Silver-containing antimicrobial articles and methods of manufacture |
| CN104941004B (en) | 2009-11-25 | 2018-09-14 | 扩散技术公司 | The rear loading method of the plastics of zeolite is adulterated with antimicrobial metal ion pair |
| BR112012016027B1 (en) | 2009-12-11 | 2019-01-15 | Difusion Technologies, Inc. | production method of polyetheretherketone antimicrobial implants |
| US9107765B2 (en) | 2010-05-07 | 2015-08-18 | Difusion Technologies, Inc. | Medical implants with increased hydrophilicity |
| GB201020236D0 (en) | 2010-11-30 | 2011-01-12 | Convatec Technologies Inc | A composition for detecting biofilms on viable tissues |
| AU2013366038A1 (en) | 2012-12-20 | 2015-07-16 | Convatec Technologies Inc. | Processing of chemically modified cellulosic fibres |
| EP3015422A4 (en) | 2013-06-25 | 2017-01-04 | Servicios Administrativos Peñoles SA de CV | Bacteriostatic and fungistatic additive in masterbatch for application in plastics, and method for producing same |
| WO2017127369A1 (en) * | 2016-01-19 | 2017-07-27 | Kci Usa, Inc. | A silicone wound contact layer with silver |
| CN109069791B (en) | 2016-03-14 | 2021-03-26 | 观察医学有限责任公司 | Biofilm prevention element in a catheter system |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2521713A (en) * | 1945-07-23 | 1950-09-12 | Sunshine Mining Company | Method for producing a microbicidal composition of matter |
| US2785106A (en) * | 1952-08-16 | 1957-03-12 | Ions Exchange And Chemical Cor | Process for making antiseptic article |
| US2813059A (en) * | 1954-11-12 | 1957-11-12 | A O Edwards | Oligodynamic silver treating process and microbicidal product |
| US3396727A (en) * | 1964-01-06 | 1968-08-13 | Nolte Albert C Jr | Drainage tube for body fluids provided with filtering means coated with bacterial preventive material |
| NL126099C (en) * | 1964-11-02 | 1900-01-01 | ||
| US3566874A (en) * | 1968-08-13 | 1971-03-02 | Nat Patent Dev Corp | Catheter |
| US3695921A (en) * | 1970-09-09 | 1972-10-03 | Nat Patent Dev Corp | Method of coating a catheter |
| US3928502A (en) * | 1971-08-04 | 1975-12-23 | Gen Tire & Rubber Co | Processable non-burning ABS-PVC blends |
| US4027393A (en) * | 1975-09-19 | 1977-06-07 | Sybron Corporation | Method of in vivo sterilization of surgical implantables |
| US4054139A (en) * | 1975-11-20 | 1977-10-18 | Crossley Kent B | Oligodynamic catheter |
| DE2720776C2 (en) * | 1977-05-09 | 1985-10-03 | Hiroshi Tokio/Tokyo Akiyama | catheter |
| GB2073024B (en) * | 1980-03-27 | 1984-06-27 | Nat Res Dev | Antimicrobial surgical implants |
| JPS5942022B2 (en) * | 1981-08-31 | 1984-10-12 | 電気化学工業株式会社 | ABS resin composition |
| DE3228849C2 (en) * | 1982-08-02 | 1989-06-08 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München | Medical device to be inserted into the body |
-
1983
- 1983-09-15 EP EP19830903140 patent/EP0124536A4/en not_active Withdrawn
- 1983-09-15 WO PCT/US1983/001404 patent/WO1984001721A1/en not_active Application Discontinuation
- 1983-10-14 CA CA000439002A patent/CA1224717A/en not_active Expired
- 1983-11-05 ES ES527051A patent/ES527051A0/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ES8504464A1 (en) | 1985-05-01 |
| EP0124536A4 (en) | 1985-06-06 |
| WO1984001721A1 (en) | 1984-05-10 |
| ES527051A0 (en) | 1985-05-01 |
| EP0124536A1 (en) | 1984-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1224717A (en) | Antimicrobial compositions | |
| AU582796B2 (en) | Antimicrobial compositions | |
| US4677143A (en) | Antimicrobial compositions | |
| US6645483B2 (en) | Lubricious coating | |
| EP0379271B1 (en) | Anti-infective and lubricious medical articles and method for their preparation | |
| EP1265650B1 (en) | Polymer compositions containing colloids of silver salts | |
| US7381751B2 (en) | Antimicrobial composition for medical articles | |
| US4592920A (en) | Method for the production of an antimicrobial catheter | |
| US7141246B2 (en) | Lubricious coating | |
| US20060045899A1 (en) | Antimicrobial composition for medical articles | |
| EP0761243A1 (en) | Biostatic coatings and processes | |
| CA2168729A1 (en) | Infection resistant medical devices | |
| WO2000030697A1 (en) | Antibiotic hydrophilic polymer coating | |
| US20040106912A1 (en) | Method and composition for producing catheters with antibacterial property | |
| EP1343546B1 (en) | Lubricious coating comprising pharmacological additives | |
| WO1997045066A1 (en) | Urinary medical devices | |
| JPH0634817B2 (en) | Method for manufacturing antibacterial urinary catheter | |
| AU2002246277A1 (en) | Lubricious coating comprising pharmacological additives | |
| CN110201244B (en) | Lyophobic low functional catheter that glues | |
| JP2636838B2 (en) | Antimicrobial sustained release urinary catheter | |
| JPH1085320A (en) | Biostatic coatings and processes | |
| MXPA03011779A (en) | Method for assembly and/or disassembly of an electronic module on an application card method for production and corresponding mechanical fixing clip. | |
| JPH05220216A (en) | In vivo insertion tube |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |